What is the difference between Semaglutide and Liraglutide?

Semaglutide (CAS 910463-68-6) is used in GLP-1 receptor agonism and metabolic research. Liraglutide (CAS 204656-20-2) is used in GLP-1 receptor and metabolic pathway research. The key research differences relate to mechanism of action, receptor selectivity, and experimental endpoints.

Which is better for research — Semaglutide or Liraglutide?

The choice between Semaglutide and Liraglutide depends on your research question. Semaglutide is preferred for studies focused on GLP-1 receptor agonism and metabolic research. Liraglutide is preferred for GLP-1 receptor and metabolic pathway research. Many research programmes study both compounds.

Can Semaglutide and Liraglutide be used together in research?

Combination studies of Semaglutide and Liraglutide are an active area of research. Consult published literature for combination protocols relevant to your specific research model.

What purity grade is recommended for Semaglutide vs Liraglutide research?

Both Semaglutide and Liraglutide should be sourced at 98%+ purity for reliable research results. Aarise Healthcare supplies both compounds at 98%+ HPLC-verified purity with independent CoA.

Semaglutide vs Liraglutide — Research Comparison

⚠ Research Use Only: All compounds supplied by Aarise Healthcare are strictly for laboratory research and scientific investigation. Not for human consumption, therapeutic use, or clinical application. Buyers must comply with all applicable local laws and regulations.

A research reference comparing Semaglutide and Liraglutide — GLP-1 receptor agonist research comparison — older vs newer generation. This comparison is for scientific research reference only.

Side-by-Side Comparison

Property	Semaglutide	Liraglutide
CAS Number	910463-68-6	204656-20-2
Category	GLP-1 Agonist	GLP-1 Agonist
Research Use	GLP-1 receptor agonism and metabolic research	GLP-1 receptor and metabolic pathway research
Purity (Aarise)	98%+ HPLC	98%+ HPLC
Form	Lyophilised powder	Lyophilised powder

Research Applications

Semaglutide is primarily studied for GLP-1 receptor agonism and metabolic research. Liraglutide is studied for GLP-1 receptor and metabolic pathway research. Researchers choose between these compounds based on their specific experimental model and endpoints.

Source Both Compounds from Aarise Healthcare

Aarise Healthcare supplies both Semaglutide and Liraglutide at 98%+ purity from our WHO-GMP certified facility. Order both compounds together for consistent quality across your comparative research programme.

Request pricing for Semaglutide and Liraglutide: Contact our research supply team with your quantity requirements. We respond within 24 hours.